275 related articles for article (PubMed ID: 26963326)
41. Determinants of Citation Impact in Large Clinical Trials in Critical Care: The Role of Investigator-Led Clinical Trials Groups.
Marshall JC; Kwong W; Kommaraju K; Burns KE
Crit Care Med; 2016 Apr; 44(4):663-70. PubMed ID: 26571189
[TBL] [Abstract][Full Text] [Related]
42. Statistical fragility of randomized clinical trials in shoulder arthroplasty.
McCormick KL; Tedesco LJ; Swindell HW; Forrester LA; Jobin CM; Levine WN
J Shoulder Elbow Surg; 2021 Aug; 30(8):1787-1793. PubMed ID: 33271323
[TBL] [Abstract][Full Text] [Related]
43. Fragility Index in Randomized Controlled Trials of Ischemic Stroke.
Sato K; Toda T; Iwata A
J Stroke Cerebrovasc Dis; 2019 May; 28(5):1290-1294. PubMed ID: 30765294
[TBL] [Abstract][Full Text] [Related]
44. The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses.
Atal I; Porcher R; Boutron I; Ravaud P
J Clin Epidemiol; 2019 Jul; 111():32-40. PubMed ID: 30940600
[TBL] [Abstract][Full Text] [Related]
45. The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care.
Tignanelli CJ; Napolitano LM
JAMA Surg; 2019 Jan; 154(1):74-79. PubMed ID: 30422256
[TBL] [Abstract][Full Text] [Related]
46. Fragility Index in Multicenter Randomized Controlled Trials in Critical Care Medicine That Have Shown Reduced Mortality.
Vargas M; Buonano P; Marra A; Iacovazzo C; Servillo G
Crit Care Med; 2020 Mar; 48(3):e250-e251. PubMed ID: 32058390
[No Abstract] [Full Text] [Related]
47. Assessing the robustness of results from clinical trials and meta-analyses with the fragility index.
Lin L; Xing A; Chu H; Murad MH; Xu C; Baer BR; Wells MT; Sanchez-Ramos L
Am J Obstet Gynecol; 2023 Mar; 228(3):276-282. PubMed ID: 36084702
[TBL] [Abstract][Full Text] [Related]
48. The fragility index: how robust are the outcomes of head and neck cancer randomised, controlled trials?
Suresh NV; Go BC; Fritz CG; Harris J; Ahluwalia V; Xu K; Lu J; Rajasekaran K
J Laryngol Otol; 2024 Apr; 138(4):451-456. PubMed ID: 37795709
[TBL] [Abstract][Full Text] [Related]
49. Effect sizes in ongoing randomized controlled critical care trials.
Ridgeon EE; Bellomo R; Aberegg SK; Sweeney RM; Varughese RS; Landoni G; Young PJ
Crit Care; 2017 Jun; 21(1):132. PubMed ID: 28583149
[TBL] [Abstract][Full Text] [Related]
50. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail?
Ospina-Tascón GA; Büchele GL; Vincent JL
Crit Care Med; 2008 Apr; 36(4):1311-22. PubMed ID: 18379260
[TBL] [Abstract][Full Text] [Related]
51. The Fragility of Statistical Significance in Patellofemoral Instability Research: A Systematic Review.
Constant M; Trofa DP; Saltzman BM; Ahmad CS; Li X; Parisien RL
Am J Sports Med; 2022 Nov; 50(13):3714-3718. PubMed ID: 34633219
[TBL] [Abstract][Full Text] [Related]
52. Can We Trust Observational Studies Using Propensity Scores in the Critical Care Literature? A Systematic Comparison With Randomized Clinical Trials.
Kitsios GD; Dahabreh IJ; Callahan S; Paulus JK; Campagna AC; Dargin JM
Crit Care Med; 2015 Sep; 43(9):1870-9. PubMed ID: 26086943
[TBL] [Abstract][Full Text] [Related]
53. Fragility of clinical trials across research fields: A synthesis of methodological reviews.
Holek M; Bdair F; Khan M; Walsh M; Devereaux PJ; Walter SD; Thabane L; Mbuagbaw L
Contemp Clin Trials; 2020 Oct; 97():106151. PubMed ID: 32942056
[TBL] [Abstract][Full Text] [Related]
54. Why do multicenter randomized controlled trials not confirm the positive findings of single center randomized controlled trials in acute care?
Landoni G; Pieri M; Young PJ; Bellomo R
Minerva Anestesiol; 2019 Feb; 85(2):194-200. PubMed ID: 30394068
[TBL] [Abstract][Full Text] [Related]
55. The Fragility Index of Randomized Controlled Trials for Preterm Neonates.
Li H; Liang Z; Meng Q; Huang X
Front Pediatr; 2022; 10():876366. PubMed ID: 35615631
[TBL] [Abstract][Full Text] [Related]
56. The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19.
Itaya T; Isobe Y; Suzuki S; Koike K; Nishigaki M; Yamamoto Y
JAMA Netw Open; 2022 Mar; 5(3):e222973. PubMed ID: 35302631
[TBL] [Abstract][Full Text] [Related]
57. Quality of reporting of randomised controlled trials in the intensive care literature. A systematic analysis of papers published in Intensive Care Medicine over 26 years.
Latronico N; Botteri M; Minelli C; Zanotti C; Bertolini G; Candiani A
Intensive Care Med; 2002 Sep; 28(9):1316-23. PubMed ID: 12209283
[TBL] [Abstract][Full Text] [Related]
58. Unbreakable? An analysis of the fragility of randomized trials that support diabetes treatment guidelines.
Chase Kruse B; Matt Vassar B
Diabetes Res Clin Pract; 2017 Dec; 134():91-105. PubMed ID: 29037877
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
